Alkermes plc

Informe acción NasdaqGS:ALKS

Capitalización de mercado: US$4.2b

Salud financiera de hoja de balance de Alkermes

Salud financiera controles de criterios 5/6

Alkermes tiene un patrimonio de accionistas total de $1.2B y una deuda total de $290.7M, lo que sitúa su ratio deuda-patrimonio en 24.2%. Sus activos y pasivos totales son $2.1B y $933.5M respectivamente. El BAIT de Alkermes es de $420.1M, por lo que su ratio de cobertura de intereses es de -53.7. Tiene efectivo e inversiones a corto plazo que ascienden a $773.5M.

Información clave

24.2%

Ratio deuda-patrimonio

US$290.73m

Deuda

Ratio de cobertura de intereses-53.7x
EfectivoUS$773.49m
PatrimonioUS$1.20b
Total pasivoUS$933.54m
Activos totalesUS$2.14b

Actualizaciones recientes sobre salud financiera

Recent updates

Alkermes: Waking Up Narcolepsy Treatment With Promising Trial Data

Apr 09

Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?

Apr 08
Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?

Alkermes: Slimmed-Down Pharma Not A Compelling Growth Story Yet

Jan 26

Is Alkermes (NASDAQ:ALKS) Using Too Much Debt?

Nov 01
Is Alkermes (NASDAQ:ALKS) Using Too Much Debt?

Alkermes' (NASDAQ:ALKS) Earnings May Just Be The Starting Point

Nov 01
Alkermes' (NASDAQ:ALKS) Earnings May Just Be The Starting Point

Is Alkermes (NASDAQ:ALKS) Using Debt Sensibly?

Jul 15
Is Alkermes (NASDAQ:ALKS) Using Debt Sensibly?

There Is A Reason Alkermes plc's (NASDAQ:ALKS) Price Is Undemanding

Jun 07
There Is A Reason Alkermes plc's (NASDAQ:ALKS) Price Is Undemanding

Is Alkermes plc (NASDAQ:ALKS) Trading At A 44% Discount?

Apr 10
Is Alkermes plc (NASDAQ:ALKS) Trading At A 44% Discount?

Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?

Mar 20
Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?

Alkermes upgraded to neutral at BofA on improved risk/reward outlook

Oct 14

Alkermes holder Sarissa Capital says it may look to increase its stake

Oct 07

Alkermes: Nothing Stands Out As Interesting

Sep 26

Health Check: How Prudently Does Alkermes (NASDAQ:ALKS) Use Debt?

Aug 29
Health Check: How Prudently Does Alkermes (NASDAQ:ALKS) Use Debt?

Alkermes initiated at neutral at Piper Sandler as company in transition

Aug 16

Alkermes Q2 2022 Earnings Preview

Jul 26

Is There An Opportunity With Alkermes plc's (NASDAQ:ALKS) 44% Undervaluation?

Jun 27
Is There An Opportunity With Alkermes plc's (NASDAQ:ALKS) 44% Undervaluation?

Alkermes (NASDAQ:ALKS) Has Debt But No Earnings; Should You Worry?

May 16
Alkermes (NASDAQ:ALKS) Has Debt But No Earnings; Should You Worry?

Alkermes: Turning The Tides Towards Profitability

Apr 16

Alkermes (NASDAQ:ALKS) Has Debt But No Earnings; Should You Worry?

Feb 07
Alkermes (NASDAQ:ALKS) Has Debt But No Earnings; Should You Worry?

Alkermes plc's (NASDAQ:ALKS) Intrinsic Value Is Potentially 100% Above Its Share Price

Jan 12
Alkermes plc's (NASDAQ:ALKS) Intrinsic Value Is Potentially 100% Above Its Share Price

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($1.5B) de ALKS superan a sus pasivos a corto plazo ($520.2M).

Pasivo a largo plazo: Los activos a corto plazo de ALKS ($1.5B) superan a sus pasivos a largo plazo ($413.3M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: ALKS tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de ALKS ha crecido de 23.8% a 24.2% en los últimos 5 años.

Cobertura de la deuda: La deuda de ALKS está bien cubierta por el flujo de caja operativo (138.1%).

Cobertura de intereses: ALKS gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.


Hoja de balance


Descubre empresas con salud financiera

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target